Company Filing History:
7 out of 1,271 
4 out of 9 
1 out of 521 Years Active: 1996-2004
Title: Innovations in Ciliary Dyskinesia Treatment: The Contributions of Monroe Jackson Stutts
Introduction
Monroe Jackson Stutts, an accomplished inventor based in Chapel Hill, North Carolina, has made significant strides in the field of medical innovations. With a total of 12 patents to his name, his work focuses primarily on methods for treating ciliary dyskinesia and related conditions. His expertise has led to advancements in stimulating ciliary function, which is essential for effective mucociliary clearance in various organs.
Latest Patents
Among Stutts' notable innovations are several patents focusing on the treatment of ciliary dyskinesia. His latest patents include:
1. **Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues** - This invention is designed to stimulate ciliary beat frequency, aiding in the clearance of retained mucus from the lungs, sinuses, and various other body systems. The method involves administering compounds like uridine triphosphates, adenosine triphosphates, or cytidine triphosphates to the patient.
2. **Method of treating ciliary dyskinesia with uridine triphosphates and related compounds** - This patent discloses a method for stimulating ciliary beat frequency through the administration of triphosphate nucleotides, particularly uridine 5′-triphosphate (UTP). The applications for this method are extensive, addressing issues related to ciliary dysfunction, including male infertility and immune deficiencies.
Career Highlights
Stutts has been associated with prominent institutions, including the University of North Carolina at Chapel Hill and Molichem Medicines, Inc. His work at these organizations underscores his commitment to pioneering research and development in the field of respiratory and reproductive health. Through his patents, he has contributed significantly to the understanding and treatment of conditions related to ciliary movement.
Collaborations
Throughout his career, Monroe Jackson Stutts has collaborated with esteemed colleagues such as Richard C. Boucher and Luis Miguel Molina Y Vedia. These partnerships have played a crucial role in enhancing the scope and impact of his research, facilitating advancements in therapeutic methods for patients with ciliary motion disorders.
Conclusion
Monroe Jackson Stutts stands out as a key inventor in the realm of medical innovation, particularly in treating ciliary dyskinesia. His numerous patents reflect a dedication to improving patient outcomes through novel treatment strategies. As research continues to evolve, Stutts' contributions will likely remain influential in the ongoing quest to address the complexities of ciliary dysfunction.